Evidence map›Paper›PMID 38931900›Full record

ArticlePharmaceutics2024

Dual Effect by Chemical Electron Transfer Enhanced siRNA Lipid Nanoparticles: Reactive Oxygen Species-Triggered Tumor Cell Killing Aggravated by Nrf2 Gene Silencing.

Fengrong Zhang, Tobias Burghardt, Miriam Höhn, Ernst Wagner

Abstract read
In one paragraph

Article in Pharmaceutics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Fengrong ZhangPharmaceutical Biotechnology, Center for Nanoscience, Ludwig-Maximilians-Universität (LMU) Munich, 81377 Munich, Germany.
Tobias BurghardtPharmaceutical Biotechnology, Center for Nanoscience, Ludwig-Maximilians-Universität (LMU) Munich, 81377 Munich, Germany.
Miriam HöhnPharmaceutical Biotechnology, Center for Nanoscience, Ludwig-Maximilians-Universität (LMU) Munich, 81377 Munich, Germany.
Ernst WagnerPharmaceutical Biotechnology, Center for Nanoscience, Ludwig-Maximilians-Universität (LMU) Munich, 81377 Munich, Germany.ORCID 0000-0001-8413-0934

Funding

China Scholarship Council 202006880011DFG (German Research Foundation) Collaborative Research Centers SFB1032 B4
6 · The paper itself

Abstract

Insufficient endosomal escape presents a major hurdle for successful nucleic acid therapy. Here, for the first time, a chemical electron transfer (CET) system was integrated into small interfering RNA (siRNA) lipid nanoparticles (LNPs). The CET acceptor can be chemically excited using the generated energy between the donor and hydrogen peroxide, which triggers the generation of reactive oxygen species (ROS), promoting endosomal lipid membrane destabilization. Tetra-oleoyl tri-lysino succinoyl tetraethylene pentamine was included as an ionizable lipopeptide with a U-shaped topology for effective siRNA encapsulation and pH-induced endosomal escape. LNPs loaded with siRNA and CET components demonstrated a more efficient endosomal escape, as evidenced by a galectin-8-mRuby reporter; ROS significantly augmented galectin-8 recruitment by at least threefold compared with the control groups, with a

Indexed as

chemical electron transferendosomal escapelipid nanoparticlesreactive oxygen speciessmall interfering RNA

Identifiers

PMID38931900
PMCPMC11207527

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.